Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-10
1999-01-05
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 5142225, 5142235, 5142242, 5142268, 5142275, 5142288, 5142292, 5142305, 5142308, 5142378, 514241, 514242, 514243, 514246, 514247, 514248, 514249, 514255, 514256, 514258, 514259, 514261, 514262, 514263, 514270, 514274, A61K 31415, A61K 3142, A61K 31425, A61K 3152
Patent
active
058563318
ABSTRACT:
There is disclosed a method for preventing tissue injury caused by tissue hypoxia and reoxygenation, comprising administering a compound that inhibits signal transduction by inhibiting cellular accumulation of linoleoyl phosphatidic acid (PA) through an inhibition of the enzyme LPAAT (lysophosphatidic acyltransferase).
REFERENCES:
patent: 4515795 (1985-05-01), Hinze et al.
patent: 5272153 (1993-12-01), Mandell et al.
patent: 5409935 (1995-04-01), Schubert et al.
patent: 5641783 (1997-06-01), Klein et al.
Abraham, E. et al., "Hemorrhage in Mice Produces Alterations in B Cell Repertoires", Cellular Immunology, 122, pp. 208-217 (1989).
Abraham, E. et al., "Effects of Hemorrhage on Interleukin-1 Production", Circulatory Shock, 25:33-40 (1988).
Abraham, E. et al., "Hemorrhage Produces Abnormalities in Lymphocyte Function and Lymphokine Generation", The Journal of Immunology, vol. 142, 899-906, No. 3 (1989).
Baker, C. C. et al., "Epidemiology of Trauma Deaths", The American Journal of Surgery, pp. 144-150 (1980).
Bursten, S. et al., "CT-150 1R Inhibits Rapid Synthesis of Specific Phosphatidic Acid (PA) Species Following Stimulation of Tumor Necrosis Factor Alpha (TNF.alpha.) Type I but not Type II Receptors" (Abstract), Hematopoietic Growth Factors-II, p. 1436. (1990).
Ertel, W. et al., "Anti-TNF Monoclonal Antibodies Prevent Haemorrhage-Induced Suppression of Kupffer Cell Antigen Presentation and MHC Class II Antigen Expression," Immunology, 74 pp. 290-297 (1991).
Hammerschmidt, D. et al., "Association of Complement Activation and Elevated Plasma-C5a with Adult Respiratory Distress Syndrome", The Lancet, pp. 947-845, May 3, 1980.
Hoch, R. C. et al., "Effects of Accidental Trauma on Cytokine and Endotoxin Production," Critical Care Medicine, 21, No. 6, (1993).
Klocking, H.-P. et al., "Release of Plasminogen Activator By Pentoxifyline and its Major Metabolite", Thrombosis Research 46; pp. 747-750 (1987).
Leff, Jonathan et al., "Serum Antioxidants as Predictors of Adult Respiratory Distress Syndrome in Patients with Sepsis," The Lancet, 341, pp. 777-780, (1993).
Marzi, Ingo, "Value of Superoxide Dismutase for Prevention of Multiple Organ Failure After Multiple Trauma", The Journal of Trauma, 35, No. 1, pp. 110-120. (1991).
McElvaney, N. et al., "Aerosol .alpha.1-antitrypsin Treatment for Cystic Fibrosis", The Lancet, 337, pp. 392-394, (1991).
Meldrum, Daniel R. et al., "Diltiazem Restores IL-2, IL-3, IL-6, and IFN-.gamma. Synthesis and Decreases Host Susceptibility to Sepsis following Hemorrhage", Journal of Surgical Research, 51, pp. 158-164 (1991).
Moore, F. A. et al., "Gut Bacterial Translocation via the Portal Vein: A Clinical Perspective with Major Torso Trauma", The Journal of Trauma, 31, No. 5, pp. 629-638 (1991).
Nakamura, H. et al., "Neutrophil Elastase in Respiratory Epithelial Lining Fluid of Individuals with Cystic Fibrosis Induces Interleukin-8 Gene Expression in a Human Bronchial Epithelial Cell Line", The Journal of Clinical Investigation, Inc., 89, pp. 1478-1484 (1992).
Pepe, Paul et al., "Clinical Predictors of the Adult Respiratory Distress Syndrome", The American Journal of Surgery, pp. 124-130. (1992).
Repine, John E., "Scientific Perspective on Adult Respiratory Distress", The Lancet, 339, (1992).
Rice, G. et al., "Protection Against Endotoxic Shock in Mice by a New Class of Synthetic Phospholipid Second Messenger Inhibitors", Cytokines and Cytokine Receptors: From Cloning to the Clinic (Abstract), p. 107. (1991).
Rice, Glenn et al., "Protection from Endotoxic Shock in Mice by Pharmacologic Inhibition of Phosphatidic Acid", Proc. Natl. Acad. Sci. USA, 91, pp. 3857-3861 (1994).
Rinehart, John et al., "Corticosteroid Modulation of Interleukin-1 Hematopoietic Effects and Toxicity in a Murine System", Blood, 84, No. 5 (pp. 1457-1463 (1994).
Riordan, John et al., "Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA" Science, 245, pp. 1066-1073, (1989).
Robinson, A. et al., "Effects of Haemorrhage on Bacterial Antigen Specific Pulmonary Plasma Cell Function", Clin. Exp. Immunol., 88, pp. 124-128 (1992).
Robinson, A. and Abraham, E., "Hemorrhage in Mice Produces Alterations in Pulmonary B Cell Repertoires", The Journal of Immunology, 146; pp. 3734-3739 (1990).
Semmler, J. et al., "Xanthine Derivatives: Comparison between Suppression of Tumour Necrosis Factor-.alpha. Production and Inhibition of cAMP Phosphodiesterase Activity", Immunology, 78, pp. 52 525, (1993).
Shenkar, R. and Abraham E., "Effects of Hemorrhage on Cytokine Gene Transcription", Lymphokine and Cytokine Research, 12, No. 4, pp. 237-246 (1993).
Sibille, Y. and Reynolds, H. "Macrophages and Polymorphonuclear Neutrophils in Lung Defense and Injury", Am. Rev. Respir. Dis., 141, pp. 471-501 (1990).
Sullivan, Gail et al., "Inhibition of the Inflammatory Action of Interleukin-1 and Tumor Necrosis Factor (Alpha) on Neutrophil Function by Pentoxifyline" Infection and Immunity, 56, pp. 1722-1729 (1988).
Terada, L. et al., "Hypoxia Injures Endothelial Cells by Increasing Endogenous Xanthine Oxidase Activity", Proc. Natl. Acad. Sci. USA, 89, pp. 3362-3366 (1992).
Tranquille, N. and Emeis, J. J., "The Effect of Pentoxifylline (Trental) and Two Analogues, BL 194 and HWA 448, on the Release of Plasminogen Activators and von Willebrand Factor in Rats", Journal of Cardiovascular Pharmacology, 18, pp. 35-42 (1991).
Chemical Abstracts; vol. 119; No. 224878r (Harada et al.) 1989.
Bursten Stuart L.
Rice Glenn C.
Singer Jack W.
Cell Therapeutics Inc.
Criares Theodore J.
LandOfFree
Method for preventing tissue injury from hypoxia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing tissue injury from hypoxia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing tissue injury from hypoxia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-862558